2004
DOI: 10.4049/jimmunol.173.11.7062
|View full text |Cite
|
Sign up to set email alerts
|

Self-Reactive T Cell Receptor-Reactive CD8+ T Cells Inhibit T Cell Lymphoma Growth In Vivo

Abstract: Syngenic C57BL/6 mice (H-2b) vaccinated with mitomycin C-treated L12R4 T lymphoma cells develop protective immunity toward the MHC class II-negative tumor cells. In the present study, we characterize the nature, mode of function, and specificity of the effector cells in this immunity. These cells are TCR-specific CD8+ T lymphocytes with effector function in vitro as well as in vivo upon transfer to naive mice. They produce high levels of IFN-γ and TNF-α, but little or no IL-4. By means of TCRβ-negative variant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2006
2006
2012
2012

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(19 citation statements)
references
References 39 publications
0
19
0
Order By: Relevance
“…The general mechanisms for tumour suppression have been principally attributed to CD4 + T helper lymphocytes. Cytokines and lymphokines from CD4 + T cells can also activate CD8 + CTL, NK cells and macrophages, which have all been shown to be involved in tumour immunity [13][14][15][16][17]. Additionally, regulatory T cells (CD4 + CD25 + ) have suppressive effects on the development of tumourassociated antigen-reactive lymphocytes [18].…”
Section: Reactive Microenvironment and Non-hodgkin's Lymphoma: Differmentioning
confidence: 97%
“…The general mechanisms for tumour suppression have been principally attributed to CD4 + T helper lymphocytes. Cytokines and lymphokines from CD4 + T cells can also activate CD8 + CTL, NK cells and macrophages, which have all been shown to be involved in tumour immunity [13][14][15][16][17]. Additionally, regulatory T cells (CD4 + CD25 + ) have suppressive effects on the development of tumourassociated antigen-reactive lymphocytes [18].…”
Section: Reactive Microenvironment and Non-hodgkin's Lymphoma: Differmentioning
confidence: 97%
“…CD8 T cells capable of lysing tumor cells produce high amounts of TNF, suggesting that T cell-derived TNF is important for antitumor immunity in mice [66][67][68]. PrevostBlondel et al [69] used a lung carcinoma cell transfer model, where CD8 T cells induce a protective tumor-specific response and found that tumor was not rejected when carcinoma cells were inoculated to TNF -/-hosts.…”
Section: Tnf and T Cells In Immunitymentioning
confidence: 99%
“…It is of particular notice that in most cases, mTNF on T cells, rather than soluble, was proposed to mediate tumor killing/rejection [66,67,70,71].…”
Section: Tnf and T Cells In Immunitymentioning
confidence: 99%
“…It is even more difficult to decide on what item to concentrate. I have worked on T‐lymphocyte biology during my entire career, from T‐lymphocyte reactivity and specificity [1, 2] via structures and biosynthesis of T‐cell receptors (TCR) [3–5] to T‐lymphocyte and TCR involvement in tumour immunology and autoimmunity [6, 7]. I have decided to review my work on immune responses to tumour cells as the ideas behind this work saw the light of day and matured during my post‐doctoral years in the Institute of Tumor Biology directed by George Klein (1971–73).…”
Section: Prefacementioning
confidence: 99%